Event Details
Celebrating 33 years of bringing the community together to discuss time-critical antibody engineering updates and best practices. Join leading scientists, engineers, and executives from the leading companies and academic institutions to discuss:
- Basic science of Antibody Engineering
- Antibody-based drug products in preclinical and clinical development
- Alternative scaffold and next-generation protein therapeutic development
- Novel scaffolds and preclinical/clinical data
- Creative technologies to improve drug-like and biophysical properties of new molecules
- Engineering and design strategies
- Emerging preclinical/clinical data to make better adc's, bispecifics, antibody mixtures and novel antibody molecules
- Scientific advances in bioprocessing
- Costs of developing and producing antibodies\